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Abstract—
Introduction:
The
oxyhemoglobin
dissociation curve describes the relationship between the
partial pressure of oxygen and the percent of hemoglobin
saturated with oxygen. This relationship is a sigmoidal
shaped curve.
The oxyhemoglobin dissociation curve
varies from patient to patient. If patient variability could
be determined patient specific oxygen flow rates could be
delivered. We have developed a model for characterizing
patient specific variations in SpO2. Our model predicts
saturation by generating a patient-specific oxyhemoglobin
dissociation curve. The purpose of this study was to
determine the effectiveness of our patient-specific model.
Methods: We Probed SpO2 level at various oxygen
inhalation amounts to provide input to our model. We
linearized the relationship between SpO2 and EtO2 for
each participant. We then fit a line to those linearized
data points. We used model fit error techniques to show
the ability of the model to fit volunteer and patient SpO2.
Fit results were generated by using the fitted patient
specific curve shift to estimate oxygen concentrations. Fit
errors were used to assess the model’s ability to fit SpO2
and to make an accurate patient specific oxyhemoglobin
dissociation curve . Results: Thirty subjects participated
in our volunteer study. The nominal average line is quite
close to the standard curve. The cumulative density plot of
the model fit error for the entire data set in our volunteer
study and the average for each volunteer had greater
accuracy than the standard fit. Sixty patients participated
in our clinical trial. The nominal average line is quite
different than the standard curve. The cumulative density
plot of the model fit error for the entire data set in our
clinical study and the average for each patient both had
greater accuracy than the standard fit. Discussion: This
study has shown that our model is able to fit patient
saturation values with higher accuracy compared to using
the standard oxyhemoglobin dissociation curve. We have
also shown that the variability of the ODC from patient to
patient is quite large, making predicting patient saturation
quite difficult. We have developed and tested a model for
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fitting the oxyhemoglobin dissociation curve to patients.
We have shown improved fit when compared to the
standard oxyhemoglobin dissociation curve. This model
could potentially be used to predict time to desaturation
specific to a patient.
Index Terms—Oxyhemoglobin Dissociation, Model Fit
Validation, Patient-specific Modeling

I. INTRODUCTION
oxyhemoglobin dissociation curve (ODC)
Thedescribes
the relationship between the partial
pressure of oxygen and the percent of hemoglobin
saturated with oxygen [1]. This relationship is a
sigmoidal shaped curve that typically reaches a
plateau at a partial pressure of oxygen (PO2) of 70
mm Hg and then slowly approaches 100%
saturation [2]. Below 70 mmHg the ODC has a
sharp decline (Figure 1). The plateau of the ODC
means for that portion of the curve large changes in
PO2 result in small changes in saturation while the
sharp decline means that small changes in PO2 result
in drastic changes in saturation, which can be life
threatening (Figure 2).
Monitored anesthesia care can result in druginduced respiratory depression and subsequent
desaturation [3]. For this reason, supplemental
oxygen is often given to increase PO2. However,
too much supplemental oxygen can delay the time
until respiratory depression is noticed. Recognition
that high levels of oxygen may impair detection of
hypoventilation by pulse oximetry has led to the
recommendation by some that oxygen should not be
administered during monitored anesthesia care [46]. While this may be effective, low levels of
oxygen can lead to frequent hypoxic episodes and
decrease the alveolar oxygen reserve available at
the time of a patient emergency.
Oxygen saturation is measured using pulse
oximetry. Pulse oximeters determine oxygen
saturation based on differences in light absorption
in tissues and both venous and capillary blood [2].
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Figure 1: The oxyhemoglobin dissociation curve, a
sigmoidal shaped curve which reaches a plateau and
slowly approaches 100% saturation typically at a partial
pressure of oxygen of 70 mmHg. Below 70 mmHg the
ODC has a sharp decline.

The characteristics of the ODC mean that at higher
values PO2 can drop for several minutes without any
indication by pulse oximetry. Then as PO2
continues to drop to lower values pulse oximetry
drops abruptly.
The ODC varies from patient to patient depending
on the values of different parameters (pH, T, PCO2,
[DPG]) and these variations affect the position of
the ODC but not the shape (Figure 3) [7]. The
effect on position changes the PO2 at which the
ODC plateau transitions to the sharp curve. Thus
patient-to-patient variability adds difficulty in
determining at which PO2 a patient’s saturation will
begin to decline rapidly.
Patient variability and limitations to pulse
oximetry make measuring saturation using existing
methods difficult. Maintaining sufficient levels of
saturation is challenging because the response of a
given individual to a particular oxygen flow rate is
unpredictable. The accuracy of pulse oximetry,
which ranges from ±2% to 4%, limits its utility as
an indicator of alveolar oxygen concentration [8].
Because of this error combined with the nature of
the ODC, high SpO2 could indicate a wide range of
PO2, and give no indication as to how close to the
steep portion of the curve a patient’s saturation is
(Figure 4).
If patient variability could be determined, and a
patient specific ODC could be generated, the
transition from plateau to sharp curve could be
characterized and patient specific oxygen flow rates
could be delivered and thus prevent saturation.
Patient-specific model-based oxygen delivery could
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prevent hemoglobin desaturation while maintaining
low enough oxygen levels for pulse oximetry to
provide warning of respiratory depression. One
possibility for determining patient variability is to
create a model which can use a subset of saturation
values to fit a patient specific ODC. We have
developed such a model based on an oxygen
delivery system we have developed and tested
previously [9, 10].
We have developed a model for characterizing
patient specific variations in SpO2. We have
identified patient specific variations by
characterizing a patient specific ODC. Determining
a patient specific curve relying solely on SpO2

Figure 2: The plateau of the ODC means for that portion
of the relationship large changes in Po2 (ΔA) result in
small changes in hemoglobin saturation while the sharp
decline means that small changes in Po2 (ΔB) result in
drastic changes in hemoglobin saturation.

Figure 3: The ODC varies from patient to patient
depending on the values of 4 parameters: concentration of
the hydrogen ion (pH), temperature (T), partial pressure of
carbon dioxide (PCO2), and concentration of 2,3diphosphoglycerate ([DPG]). These variations affect the
position of the ODC but not the shape. The effect on the
position changes the location of the transition from the
ODC plateau to the sharp curve.
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Where P50 is the PO2 at which 50% of hemoglobin
are saturated and where n is 2.7 in normal human
blood. The ODC can be linearized using natural
logarithms as follows:
𝑥 = 𝐿𝑛[𝑃𝑂2]; 𝑦 = ln [

Figure 4: The accuracy of pulse oximetry, which ranges
from ±2% to 4%, limits its utility as an indicator of
alveolar oxygen concentration. Because of this error band
combined with the nature of the ODC, high SpO2 could
indicate a wide range of PO2, and give no indication as to
how close to the steep portion of the curve a patient’s
saturation is.

could add value to pulse oximetry and provide a
non-invasive way to determine a patient’s curve.
Our model predicts saturation by generating a
patient-specific oxyhemoglobin dissociation curve.
The model automatically adapts to patient
variability. Such a model could also help determine
the minimum amount of oxygen necessary to
maintain satisfactory oxygenation as considerable
hyperoxia also has negative effects in some patients
[11].
The purpose of this study was to determine the
effectiveness of our patient-specific model. A
model-based and patient specific approach to
supplemental oxygen delivery could characterize
patient variability and thus provide oxygen delivery
specific to a patient’s needs [12]. This approach
would provide the ability to keep a patient saturated
sufficient enough to provide time for intervention
while still reducing fire hazard.

II. METHODS
Study approval and risk determination came from
the University of Utah Institutional Review Board.
All volunteers and patients participated in this study
with written informed consent.
A. Theory
The ODC is described using Hill’s equation:

𝑆𝐻𝑏𝑂2
]
1 − 𝑆𝐻𝑏𝑂2

We used this method to linearize the relationship
between SpO2 and EtO2 for each participant.
For each participant, the values of expected PAO2,
measured SpO2, and measured expired oxygen
concentration values were used to establish the
framework for a specific ODC. To establish a
specific ODC, we fit a line to linearized data points
and transformed that linear fit back into a patient
specific ODC.
B. Volunteer Study
During the study, our prototype system delivered
oxygen flows between 0 and 10 L/min. Each flow
rate and mode combination was delivered for two
minutes. At the end of each two-minute period,
oxygen flow was turned off and the expired oxygen
was sampled for three breaths.
C. Clinical Study
Supplemental oxygen was given using a nasal
cannula throughout the procedure. The protocol
called to deliver varying flow rates from 0.4 L/min
to 5 L/min. Each flow rate was delivered for 2
minutes. At the end of each two-minute period,
oxygen flow was turned off and the expired gas was
analyzed using for 3 breaths.
D. Model Validation
We used model fit error techniques to show the
ability of the model to fit volunteer and patient
SpO2. Fit results were generated by using the fitted
patient specific curve shift to estimate oxygen
concentrations. Fit errors were used to assess the
ability of the model to fit SpO2.
To validate our model, we tested the ability of the
volunteer developed model to fit data obtained in
the volunteer study and clinical trial. Model fit
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III. RESULTS
Figure 5 shows representative data from a clinical
trial patient. This data is an example of the ability
of our model to adapt to the patient specific points.
This model adaptation shows how, in this particular
patient, oxygen saturation would begin to drop long
before the standard ODC predicts. In this patient,
oxygen saturation reaches 98% at an end-tidal
oxygen value of approximately 50% as compared to
the standard curves estimate of a regular end-tidal
concentration obtained when breathing room air of
15%.

and the average for each volunteer had greater
accuracy than the standard fit. For the model
adapted fit, 90% of data points had an error of less
than 0.8% while for the standard fit 90% of data
points had an error less than 2.0% (Figure 7). The
largest average fit error when using our model
adapted fit was 0.3% while the largest average
standard curve fit was 2.4% (Figure 8).
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Figure 5: Representative data from a clinical trial patient.
This data is an example of the ability of our model to adapt
to the patient specific points. The model’s adaptation
shows how in this particular patient oxygen saturation
would begin to drop long before the standard ODC would
predict.

A. Volunteer Study
Thirty subjects (14 females/16 males; age: 34 ± 12
years, height: 172.4 ± 10.1 cm, weight: 75 ± 17.6
kg, mean ± SD) participated in this study. All
participants enrolled finished the study.
For our volunteer study, the nominal average line
is quite close to the standard curve (Figure 6). The
standard deviation appears to be larger to the right
compared to the left, this is most likely due to the
nature of the curve where values approach 100%
saturation asymptotically.
For both the whole data set and the average for
each volunteer, the model adapted fit (red) showed
great improvement over the standard curve fit
(black). The cumulative density plot of the model
fit error for the entire data set in our volunteer study

Nominal Average

+1 SD

-1 SD

Figure 6: Nominal curve and uncertainty for our volunteer
study with 30 healthy volunteers. The nominal average
line (solid red) is quite close to the standard curve (solid
black). Individual patient curves are shown in gray. The
standard deviations shown show a good estimation of the
variance in oxyhemoglobin dissociation curves between
volunteers. The standard deviation appears to be larger to
the right compared to the left, this is most likely due to the
nature of the curve where values approach 100%
saturation asymptotically.
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Figure 7: Cumulative density plot of the model fit error for
the entire data set in our volunteer study. The model
adapted fit (red) shows great improvement over the
standard curve fit (black). This plot demonstrates the
ability of our model to provide a more accurate estimate of
healthy volunteer saturations when compared with the
standard oxyhemoglobin dissociation curve. For the
model adapted fit, 90% of data points had an error of less
than 0.8% while for the standard fit 90% of data points had
an error less than 2.0%.
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Figure 8: Cumulative density plot of the model fit error for
our volunteer study using the average for each patient.
The average model adapted fit (red) shows great
improvement over the average standard curve fit (black).
This plot demonstrates the ability of our model to provide
a more accurate estimate of patient saturations when
compared with the standard oxyhemoglobin dissociation
curve. The largest average fit error when using our model
adapted fit was 0.3% while the largest average standard
curve fit was 2.4%.

The standard deviations shown show a good
estimation of the variance in oxyhemoglobin
dissociation curves between volunteers. This
nominal curve is a good demonstration of the
variability of the oxyhemoglobin dissociation curve
from patient to patient and the difficulty of
predicting patient saturation levels.
For both the whole data set and the average for
each patient, the model adapted fit (red) showed
great improvement over the standard curve fit
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B. Clinical Study
Sixty patients (32 females/28 males; age: 66.5 ±
12.7, height: 170.3 ± 12.2 cm, weight: 81.2 ± 19.3
kg, mean ± SD) participated in our trial and all
patients completed the study. All patients met
eligibility criteria and were recruited between
12/1/16 and 4/14/17.
For our clinical study, the nominal average line is
quite different than the standard curve (Figure 9).

Model Adapted Fit

Standard Curve Fit

Figure 10: Cumulative density plot of the model fit error
for the entire cohort in our clinical study. The model
adapted fit (red) shows great improvement over the
standard curve fit (black). This plot demonstrates the
ability of our model to provide a more accurate estimate of
patient saturations when compared with the standard
oxyhemoglobin dissociation curve. For the model adapted
fit, 90% of data points had an error of 1.3% or less while
for the standard fit 90% of data points had an error of 2.6%
or less.
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Figure 9: Nominal curve and uncertainty for our clinical
study with 60 patients. The nominal average line (solid
red) is quite different than the standard curve (solid black).
The standard deviations shown show a good estimation of
the variance in oxyhemoglobin dissociation curves
between volunteers. This nominal curve is a good
demonstration of the variability of the oxyhemoglobin
dissociation curve from patient to patient and the difficulty
of predicting patient saturation levels.

Model Adapted Fit
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Figure 11: Cumulative density plot of the model fit error
for our clinical study using the average for each patient.
The average model adapted fit (red) shows great
improvement over the average standard curve fit (black).
This plot demonstrates the ability of our model to provide
a more accurate estimate of patient saturations when
compared with the standard oxyhemoglobin dissociation
curve. The largest average fit error when using our model
adapted fit was 0.6% while the average standard curve fit
error approached 5.4%.

UTAH NASA SPACE GRANT CONSORTIUM FELLOWSHIP SYMPOSIUM PROCEEDINGS, MAY 2018

(black). The cumulative density plot of the model
fit error for the entire data set in our clinical study
and the average for each patient both had greater
accuracy than the standard fit. For the model
adapted fit, 90% of data points had an error of less
than 1.3% while for the standard fit 90% of data
points had an error less than 2.6% (Figure 10). The
largest average fit error when using our model
adapted fit was 0.6% while the largest average
standard curve fit was 5.4% (Figure 11).

IV. DISCUSSION
This study has shown that our model is able to fit
patient saturation values with higher accuracy than
when using the standard oxyhemoglobin
dissociation curve. We have also shown that the
variability of the ODC from patient to patient is
quite large, making predicting patient saturation
quite difficult.
Our results demonstrate the ability of our model
to provide a more accurate estimate of healthy
volunteer and patient saturations when compared
with the standard oxyhemoglobin dissociation
curve. These accurate estimates could help
determine a patient’s specific ODC and thus define
where on the PO2 scale the patient’s SpO2 would
start to drop drastically.
We experienced large variations in the
relationship between PO2 and SpO2 in both
volunteers and patients. The larger variation in the
relationship in patients could be attributed to the
fact that the patients underwent sedation and
experienced lower minute volume. The variation
could also be attributed to the difference in age
between the volunteers and patients. This variation
can be quite difficult to predict and our model
shows an initial step toward understanding and
predicting these differences.
Although our model was able to fit patient data
values within the range measured, we did
experience unusual behavior beyond the ranges we
tested. The model results would at times cross over
from the right side of the standard ODC to the left
side or vice versa. This behavior has not been
experienced in clinical data and may be caused by a
number of things including the ±2% error span of
SpO2 measurements and noise.
Future directions for this research include using a
subset of patient data to create a model fit and
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subsequently using that model fit to predict
remaining patient saturation values. This type of
technique would make acquiring the patient-specific
ODC less cumbersome as only a small amount of
sample points would be needed to characterize the
curve.
Once clinically validated, our model would
increase the utility of pulse oximetry measurements
when saturation is >98%. Future validation would
include predicting patient saturation for a range of
levels of supplemental O2.
A future use for this model would be to combine
the model with other existing models to simulate
and predict O2 saturation and time to apnea in
patients with varying levels of respiratory drive.
Predicting the course of SpO2 for a given amount of
time could help explore and experiment with
simulations on different clinical scenarios that may
not be safe to study in volunteers or patients.
In summary, we have developed and tested a
model for fitting the oxyhemoglobin dissociation
curve to patients. We have shown improved fit
when compared to the standard ODC. This model
could potentially be used to predict time to
desaturation specific to a patient.
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